Schonfeld Strategic Advisors’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-5,070
| Closed | -$17.2K | – | 2179 |
|
2023
Q1 | $17.2K | Sell |
5,070
-240
| -5% | -$816 | ﹤0.01% | 1772 |
|
2022
Q4 | $23.9K | Buy |
5,310
+100
| +2% | +$450 | ﹤0.01% | 2256 |
|
2022
Q3 | $46K | Buy |
5,210
+10
| +0.2% | +$88 | ﹤0.01% | 2590 |
|
2022
Q2 | $60K | Buy |
5,200
+280
| +6% | +$3.23K | ﹤0.01% | 2120 |
|
2022
Q1 | $87K | Buy |
4,920
+1,390
| +39% | +$24.6K | ﹤0.01% | 2199 |
|
2021
Q4 | $115K | Hold |
3,530
| – | – | ﹤0.01% | 1789 |
|
2021
Q3 | $142K | Buy |
+3,530
| New | +$142K | ﹤0.01% | 1776 |
|
2020
Q3 | – | Sell |
-39,934
| Closed | -$835K | – | 1479 |
|
2020
Q2 | $835K | Buy |
+39,934
| New | +$835K | 0.02% | 620 |
|
2020
Q1 | – | Sell |
-8,032
| Closed | -$90K | – | 1346 |
|
2019
Q4 | $90K | Buy |
8,032
+330
| +4% | +$3.7K | ﹤0.01% | 1213 |
|
2019
Q3 | $90K | Buy |
+7,702
| New | +$90K | ﹤0.01% | 954 |
|